AVENUE THERAPEUTICS, INC.

NEW YORK, NY How do I update this listing?

Avenue Therapeutics is based out of New York. Avenue Therapeutics, Inc. operates as a specialty pharmaceutical company. The Company focuses on the development and commercialization of products principally for use in the acute and hospital setting. Avenue Therapeutics develops an intravenous formulation of tramadol HCI for the treatment of moderate to moderately severe post-operative pain. The firm last filed a Form D notice of exempt offering of securities on 2017-01-12. The notice included securities offered of Debt

Create Alert

Contact Info

avenue therapeutics, inc.
2 GANSEVOORT STREET
NEW YORK NY    10014

Business Phone: 781-652-4500
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2017-01-12 D BIOTECHNOLOGY Debt 5,000,000 200,000 4,800,000
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
AKHTAR SAMAD, M.D. PH.D. subscription required
    DIRECTOR
DAVID J. HORIN subscription required
    EXECUTIVE OFFICER
JEFFREY PALEY, M.D. subscription required
    DIRECTOR
LINDSAY A. ROSENWALD, M.D. subscription required
    DIRECTOR
LUCY LU, M.D. subscription required
    EXECUTIVE OFFICER DIRECTOR
MICHAEL WEISS subscription required
    DIRECTOR
NEIL HERSKOWITZ subscription required
    DIRECTOR
SCOTT A. RAINES, M.D. subscription required
    EXECUTIVE OFFICER

Elevate your investments